289 related articles for article (PubMed ID: 26991144)
1. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
3. Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.
Pereda CM; Lesueur F; Pertesi M; Robinot N; Lence-Anta JJ; Turcios S; Velasco M; Chappe M; Infante I; Bustillo M; García A; Clero E; Xhaard C; Ren Y; Maillard S; Damiola F; Rubino C; Salazar S; Rodriguez R; Ortiz RM; de Vathaire F
BMC Genet; 2015 Mar; 16():22. PubMed ID: 25879635
[TBL] [Abstract][Full Text] [Related]
4. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24.
Jones AM; Howarth KM; Martin L; Gorman M; Mihai R; Moss L; Auton A; Lemon C; Mehanna H; Mohan H; Clarke SE; Wadsley J; Macias E; Coatesworth A; Beasley M; Roques T; Martin C; Ryan P; Gerrard G; Power D; Bremmer C; ; Tomlinson I; Carvajal-Carmona LG
J Med Genet; 2012 Mar; 49(3):158-63. PubMed ID: 22282540
[TBL] [Abstract][Full Text] [Related]
6. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.
Guibon J; Sugier PE; Kulkarni O; Karimi M; Bacq-Daian D; Besse C; Boland A; Adjadj E; Rachédi F; Rubino C; Xhaard C; Mulot C; Laurent-Puig P; Guizard AV; Schvartz C; Ortiz RM; Ren Y; Ostroumova E; Deleuze JF; Boutron-Ruault MC; Kesminiene A; De Vathaire F; Guénel P; Lesueur F; Truong T
Oncotarget; 2021 Mar; 12(5):493-506. PubMed ID: 33747362
[TBL] [Abstract][Full Text] [Related]
7. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
Figlioli G; Köhler A; Chen B; Elisei R; Romei C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Försti A; Gemignani F
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2084-92. PubMed ID: 25029422
[TBL] [Abstract][Full Text] [Related]
8. The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population.
Rogounovitch TI; Bychkov A; Takahashi M; Mitsutake N; Nakashima M; Nikitski AV; Hayashi T; Hirokawa M; Ishigaki K; Shigematsu K; Bogdanova T; Matsuse M; Nishihara E; Minami S; Yamanouchi K; Ito M; Kawaguchi T; Kondo H; Takamura N; Ito Y; Miyauchi A; Matsuda F; Yamashita S; Saenko VA
Thyroid; 2015 Mar; 25(3):333-40. PubMed ID: 25562676
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
10. Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.
Kula D; Kalemba M; Puch Z; Polańska J; Świerniak M; Rusinek D; Żebracka-Gala J; Kowalska M; Handkiewicz-Junak D; Kowal M; Tyszkiewicz T; Piasna E; Czarniecka A; Pawlaczek A; Krajewska J; Szpak-Ulczok S; Jarząb B
Endokrynol Pol; 2017; 68(3):283-289. PubMed ID: 28660995
[TBL] [Abstract][Full Text] [Related]
11. Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
Truong T; Lesueur F; Sugier PE; Guibon J; Xhaard C; Karimi M; Kulkarni O; Lucotte EA; Bacq-Daian D; Boland-Auge A; Mulot C; Laurent-Puig P; Schvartz C; Guizard AV; Ren Y; Adjadj E; Rachédi F; Borson-Chazot F; Ortiz RM; Lence-Anta JJ; Pereda CM; Comiskey DF; He H; Liyanarachchi S; de la Chapelle A; Elisei R; Gemignani F; Thomsen H; Forsti A; Herzig AF; Leutenegger AL; Rubino C; Ostroumova E; Kesminiene A; Boutron-Ruault MC; Deleuze JF; Guénel P; de Vathaire F
Int J Cancer; 2021 Jun; 148(12):2935-2946. PubMed ID: 33527407
[TBL] [Abstract][Full Text] [Related]
12. Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis.
Ai L; Liu X; Yao Y; Yu Y; Sun H; Yu Q
Endocrine; 2014 Nov; 47(2):428-34. PubMed ID: 24723258
[TBL] [Abstract][Full Text] [Related]
13. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.
Gudmundsson J; Sulem P; Gudbjartsson DF; Jonasson JG; Sigurdsson A; Bergthorsson JT; He H; Blondal T; Geller F; Jakobsdottir M; Magnusdottir DN; Matthiasdottir S; Stacey SN; Skarphedinsson OB; Helgadottir H; Li W; Nagy R; Aguillo E; Faure E; Prats E; Saez B; Martinez M; Eyjolfsson GI; Bjornsdottir US; Holm H; Kristjansson K; Frigge ML; Kristvinsson H; Gulcher JR; Jonsson T; Rafnar T; Hjartarsson H; Mayordomo JI; de la Chapelle A; Hrafnkelsson J; Thorsteinsdottir U; Kong A; Stefansson K
Nat Genet; 2009 Apr; 41(4):460-4. PubMed ID: 19198613
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study on differentiated thyroid cancer.
Köhler A; Chen B; Gemignani F; Elisei R; Romei C; Figlioli G; Cipollini M; Cristaudo A; Bambi F; Hoffmann P; Herms S; Kalemba M; Kula D; Harris S; Broderick P; Houlston R; Pastor S; Marcos R; Velázquez A; Jarzab B; Hemminki K; Landi S; Försti A
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1674-81. PubMed ID: 23894154
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma.
Figlioli G; Elisei R; Romei C; Melaiu O; Cipollini M; Bambi F; Chen B; Köhler A; Cristaudo A; Hemminki K; Gemignani F; Försti A; Landi S
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):700-13. PubMed ID: 26843521
[TBL] [Abstract][Full Text] [Related]
16. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.
Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T
Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of GWAS variants associated with differentiated thyroid cancer.
Jendrzejewski JP; Sworczak K; Comiskey DF; de la Chapelle A
Endokrynol Pol; 2019; 70(5):423-429. PubMed ID: 31681970
[TBL] [Abstract][Full Text] [Related]
18. Common genetic variant on 14q13.3 contributes to thyroid cancer susceptibility: evidence based on 12 studies.
Zheng J; Li C; Wang C; Ai Z
Mol Genet Genomics; 2015 Jun; 290(3):1125-33. PubMed ID: 25552255
[TBL] [Abstract][Full Text] [Related]
19. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
20. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.
Jendrzejewski J; He H; Radomska HS; Li W; Tomsic J; Liyanarachchi S; Davuluri RV; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2012 May; 109(22):8646-51. PubMed ID: 22586128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
